GlassScriptPhysician profile
Andrea W Ballengee
NPI 1912522426
$879.35
in general payments reported to CMS, 2019-2025
7 companies · $239 in 2025
The $239 reported for 2025 was more than what 79% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $9.42 · 2021: $75.00 · 2022: $134 · 2023: $25.00 · 2024: $397 · 2025: $239.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $536 · Education: $100 · Consulting Fee: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $536.10 |
| Education | $100.00 |
| Consulting Fee | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $433.56 | 2024-2025 | |
| Zimmer Biomet Holdings, INC. | $150.00 | 2021-2022 | |
| Dentsply Sirona INC | $149.93 | 2022-2024 | Implant Dentistry, Waveone Gold Conform Fit |
| Align Technology, INC. | $61.52 | 2020-2025 | Invisalign, Itero |
| Nusmile, LTD. | $49.05 | 2025 | Ab - Zarc System |
| Orapharma, A Division of Bausch Health US, LLC | $19.79 | 2025 | Arestin |
| Philips North America LLC | $15.50 | 2024 | (E55) Oral Health Care Und |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrea Ballengee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.